These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10370670)

  • 1. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
    Chijiiwa K; Saiki S; Tanaka M
    Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection.
    Wakabayashi H; Yachida S; Maeba T; Maeta H
    Hepatogastroenterology; 2002; 49(46):1048-52. PubMed ID: 12143199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
    Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.
    Kim YI; Song KE; Ryeon HK; Hwang YJ; Yun YK; Lee JW; Chun BY
    Hepatogastroenterology; 2002; 49(46):1077-82. PubMed ID: 12143206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
    Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a protease inhibitor against hepatectomy.
    Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
    Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight of resected liver is positively correlated with serum hHGF level.
    Miyata K; Taniguchi H; Takeuchi K; Koyama H; Tanaka H; Takahashi T
    Hepatogastroenterology; 1996; 43(12):1589-93. PubMed ID: 8975970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between human hepatocyte growth factor and interleukin-6 concentrations after surgery.
    Kimura F; Miyazaki M; Suwa T; Kadoyama C; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    Hepatogastroenterology; 1999; 46(26):1030-5. PubMed ID: 10370662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting liver regeneration after right portal vein embolization.
    Kusaka K; Imamura H; Tomiya T; Makuuchi M
    Hepatogastroenterology; 2004; 51(56):532-5. PubMed ID: 15086196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative and postoperative variations of human hepatocyte growth factor (hHGF) in hepatectomized patients].
    Ogasawara K; Hata Y; Une Y; Sasaki F; Nakajima Y; Uchino J; Ito Y; Kawai T
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):521-7. PubMed ID: 7969019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
    Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
    Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
    Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.